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The level of proviral DNA sequence variation in the V1V2 region was monitored over time in six HIV-1-infected individuals.
Substitutional and length variation was observed, where the majority of length changes, ranging from 28 to 49 amino acids,
was located within the V1 region. Evidence for convergent evolution in the V2 region was found. The functional significance
of this variation was assessed by cloning the V1V2 sequences into an infectious molecular clone, HXB2. The majority of
chimeras replicated, demonstrating that the sequences, though genetically distinct, were capable of conferring a viable
phenotype. Chimeras expressing closely related sequences in a constant genetic background displayed different biological
phenotypes, with respect to both cytopathicity and cell tropism. However, no association between primary V1V2 amino acid
sequence and viability or cytopathicity of the chimeric virus was observed, suggesting that predictions of virus phenotype
based on sequences alone may be incorrect. The effect of V1V2 variation on the overall gp120 conformation was measured
by expressing the gp120 from a number of viable and nonviable clones. No differences were observed, suggesting that
misfolding of the chimeric gp120 protein was not an explanation for the nonviability of some virus clones. Several chimeras
were noncytopathic and only able to replicate in PBMC cultures, demonstrating that the V1V2 region, independent of the
V3 sequence, is capable of defining both tropism and cytopathicity. q 1996 Academic Press, Inc.
INTRODUCTION and Myers, 1992). However, Donaldson and colleagues
(1994) have shown that the majority (241/243) of V3 se-
Viruses isolated from HIV-1-infected individuals during
quences obtained directly from different organs postmor-
the course of disease progression can change their in
tem lacks the V3 signature sequence reported to be as-
vitro properties from a nonsyncytial inducing (NSI) to a
sociated with the SI phenotype, despite extensive histo-
syncytial inducing (SI) phenotype. Generally, NSI viruses
logical evidence of cytopathology, raising some concern
replicate well in monocyte/macrophage cultures but fail
over the reliability of signature sequences as prognostic
to replicate in T-cell lines. Several reports suggest that
indicators.
the appearance of SI viruses is associated with a more
A number of reports have suggested that the V2 region
rapid CD4 cell decline and onset of symptoms (A˚sjo¨ et
may also play a role in determining differences in cell
al., 1986; Tersmette et al., 1989a,b; Schuitemaker et al.,
tropism and cytopathicity (Groenink et al., 1992, 1993;
1992; Fenyo¨, 1993; Connor and Ho, 1994; Karlsson et al.,
Westerfelt et al., 1992; Andeweg et al., 1993; Boyd et1994). The envelope glycoprotein gp120/gp41 plays an
al., 1993; Malykh et al., 1995). Envelope glycoproteinsimportant role in determining both cellular tropism and
containing either site-directed mutations in V1V2 or for-cytopathicity of the virus. Variation in gp120 is clustered
eign V2 sequences display altered cytopathicity (Ande-in five discrete hypervariable regions, V1 to V5, which
weg et al., 1993; Boyd et al., 1993; Sullivan et al., 1993;are interspersed between five conserved regions, C1 to
Freed and Martin, 1994; Koito et al., 1994, 1995). In addi-C5 (Modrow et al., 1987). The third of these variable
tion, monoclonal antibodies (mAbs) specific for the V2regions (V3) has been reported as being the primary
region are capable of blocking both cell-free virus infec-determinant of both macrophage tropism and cytopathi-
tion and cell–cell fusion (McKeating et al., 1993b; Moorecity, leading to the suggestion that ‘‘signature patterns’’
et al., 1993; Gorny et al., 1994; Warrier et al., 1994; Shottonexist for the NSI and SI phenotypes (Hwang et al., 1991;
et al., 1995; Wu et al., 1995). Interactions of gp120 withTakeuchi et al., 1991; Chesebro et al., 1992; De-Jong et
both cell surface expressed and soluble CD4 (sCD4)al., 1992; Fouchier et al., 1992; Shioda et al., 1992; Korber
modulate the exposure of the V2 region (McKeating et
al., 1993b; Moore et al., 1993; Shotton et al., 1995; Wyatt
Sequence data from this article have been deposited with the Gen-
et al., 1995). These data suggest the involvement of thisBank Data Library under Accession Nos. U52247–U52339.
region in conformational change(s) induced by receptor1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (44) 171 580 5896. E-mail: p.balfe@ucl.ac.uk. interaction which may be a prerequisite for fusion of
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the viral–cell membranes. However, the high degree of viously (Simmonds et al., 1990b). Samples were precipi-
tated with ethanol and the resulting DNA pellets resus-substitutional and length polymorphism in this domain
(Lamers et al., 1993; Wang et al., 1995) implies that its pended in 100 ml of TE buffer [10 mM Tris–HCl (pH
7.5), 1 mM EDTA]. The proviral copy number from thefunctional properties may be defined by interactions be-
tween discontinuous residues not readily apparent from equivalent of 150,000 cells (1 mg of extracted DNA deter-
mined spectrophotometrically) was estimated using lim-inspection of linear sequences. Andeweg and colleagues
(1993) suggested that a predicted a-helix in the N-termi- iting-dilution PCR as described previously (Simmonds et
al., 1990a,b).nal V2 region may be structurally important for syncytial
formation. Furthermore, Groenink and colleagues (1993) PCR amplification, cloning, and sequencing of HIV-1
concluded that both the mean length and location of V1V2 sequences
potential glycosylation sites within the V2 domain, in ad-
The PCR followed the protocols previously reporteddition to the number of positively charged amino acid
(McKeating et al., 1993a). The gp120 encoding regionresidues in both V2 and V3, were predictive of an SI or
was amplified using the primers 626 (sense) 5*-GTG GGTNSI phenotype. However, Wang and colleagues (1995)
CAC CGT CTA TTA TTG GG and 524 (antisense) 5*-CACwere unable to demonstrate any association between
CAC GCG TCT CTT TGC CTT GGT GGG using 30 cyclescytopathicity and V2 sequence of several viral isolates.
of amplification (947, 40 sec; 507, 35 sec; 727, 210 sec) inThe aim of this study was to monitor V1V2 variation
a volume of 50 ml with template containing greater thanover time in a number of infected individuals and to ana-
50 molecules of proviral DNA and 16 ng of each primer,lyze the effects of such variation on viral phenotype.
200 mM concentrations of each deoxynucleotide triphos-Since virus isolation leads to the loss of length variation
phate (dNTP), 11 PFU buffer, and 0.5 units of PFU poly-(Simmonds et al., 1990b; Wang et al., 1995) and to the
merase (Stratagene). To prevent exonucleolytic degrada-preferential amplification of SI viruses (Donaldson et al.,
tion the first round product was frozen immediately upon1994), the V1V2 region was amplified directly from the
completion of the reaction. Secondary PCR reactions us-PBMC of six infected individuals. Multiple V1V2 lengths
ing 1 ml of the primary PCR product with the followingwere cloned from each sample and the functional signifi-
primers were set up: for the V1V2 region, 589 (sense) 5*-cance of the variation was assessed by transferring a
GTG TAA AGT TAA CCC CAC TCT G and 590 (antisense)number of closely related V1V2 sequences into the mo-
5*-AAT CGC GAA ACC AGC CGG CGC ACA AT; for thelecular clone HXB2. The majority of chimeric viruses rep-
V3 region, 619 (sense) 5*-TGG CAG TCT AGC AGA AGAlicated, demonstrating that the sequences, though genet-
AG and 617 (antisense) 5*-TTA CAG TAG AAA AAT TCCically distinct, were capable of conferring a viable pheno-
CCT C. All secondary PCR reactions were carried out intype. Furthermore, several chimeric viruses were
a volume of 100 ml using 25 cycles of amplification (947,noncytopathic and only able to replicate in PBMC cul-
40 sec; 557, 35 sec; 727, 150 sec) with 32 ng of eachtures, demonstrating that the V1V2 region alone is capa-
primer, 200 mM concentrations of each dNTP, 11 PFUble of determining both cytopathicity and cell tropism.
buffer, and 2.5 units of PFU polymerase. Ten microlitersHowever, it is difficult to predict the viral phenotype of
of the PCR reaction was visualized on an agarose gel.the chimeric virus from analyzing the primary sequence,
PCR products generated with primers 589/590 were puri-suggesting that signature pattern analysis for the V2 re-
fied by the Geneclean procedure (Bio 101, La Jolla, CA)gion is not a reliable prognostic indicator. However, func-
and ligated into pGEM-T cloning vector (Promega). Liga-tional analysis of the V1V2 domain clearly shows this
tion mixtures were transformed into competent Esche-region of the envelope glycoprotein to be an important
richia coli (TG2, New England Biolabs) and individualdeterminant of viral cytopathicity and cell tropism.
colonies screened for inserts by PCR using primers 589/
590. Plasmid preparations of clones containing insertsMATERIALS AND METHODS
were prepared using Wizard miniprep kits (Promega) and
Patient samples and DNA extraction plasmids of selected V1V2 lengths (see below) se-
quenced using the M13 Forward sequencing primer (U.S.Peripheral blood samples (10-ml volume) were ob-
Biochemical Corp.) and 589/590 according to a modifica-tained from six seropositive males (CDC II) attending a
tion of the Sequenase protocol (U.S. Biochemical Corp.,
sexually transmitted disease clinic as part of a longitudi-
Cleveland, OH) (Winship, 1989). Plasmids containing
nal study of the natural history of HIV-1 infection. The
V1V2 sequences were designated according to patient
times of sampling are shown in Table 1 where all individ-
number (P1–P6), time of sampling, and length (A–E) (Ta-
uals had CD4 cell counts 200/mm3 and commenced
bles 1 and 2).
elective AZT therapy at the time of collection of the sec-
Phylogenetic analysisond sample. The PBMC were isolated by a single-step
Ficoll–Paque procedure and DNA was extracted by the Sequences were aligned using the CLUSTAL V pro-
gram by inserting gaps at codon boundaries (Higginssarkosyl–proteinase K– phenol method described pre-
AID VY 7946 / 6a18$$$441 05-28-96 14:05:56 viras AP: Virology
438 PALMER ET AL.
TABLE 1
Times of PBMC Sampling
Timing of samples (days)
Patient no. 1st 2nd 3rd 4th 5th 6th 7th
P1 0 38 85 133 199 470
P2 0 397 421 449 609 645 706
P3 0 115 141 183 396
P4 0 49 89 203
P5 0 36 49 78 134
P6 0 327 509 711
Note. The timing for the first and second samples used for sequence analysis are shown in boldface for each patient (P1–P6). Intermediate
samples from each patient were analyzed for length polymorphism (Fig. 1).
et al., 1992). The inclusion of a large number of gaps sites HpaI and NgoMI/NruI were introduced via the Kun-
kel method of mutagenesis using primers 589 and 590,complicated the interpretation of the phylogenetic rela-
tionships between the individual sequences. As there is respectively (Kunkel, 1985). The mutated fragment was
returned to HXB2.MCS and a number of clones wereno consensus on the correct interpretation of such gaps
these residues were ignored in subsequent analyses. sequenced. Three of the sequenced HXB2.HpaI/NgoMI
plasmids, together with the parental HXB2.MCS, wereThe Phylip (3.5c) suite of programs was used to construct
phylogenetic trees using maximum likelihood (Felsen- transfected into HeLa–CD4 cells using Lipofectamine
(Gibco BRL). Viruses were recovered from all transfec-stein, 1993), neighbor-joining (Saitou and Nei, 1987), and
distance methods (Hasegawa et al., 1985). Bootstrap re- tions and were shown to replicate with equivalent effi-
ciencies in T-cell lines (data not shown). Both thesampling was performed using neighbor-joining analysis
of 1000 random subsets, which confirmed the branching HXB2.HpaI/NgoMI and the pGEM-T.V1V2 plasmids were
digested with HpaI/NgoMI. The insert(s) and vector wereorder obtained by optimized global branch swapping on
the total data set (program DNAML) (Fig. 4). gel purified by the Geneclean procedure and ligated.
Transformants were screened for insert by PCR and by
the presence of a synthetic NruI site, and plasmids wereAmplification of the V1/V2 and V3 regions for
sequenced to verify the presence of the correct insert.analysis of length polymorphism
Aliquots of DNA containing 50 to 100 molecules of Transfection of HXB2.V1V2 chimeric clones and
proviral DNA were used as template in a nested PCR as biological characterization of recovered virus
above. A 1-ml sample of the 626/524 primary PCR reac-
All HXB2.V1V2 plasmids (5 mg) were transfected intotion was used as a template in three separate reactions
both HeLa and HeLa–CD4 cells using Lipofectamineusing primers 589/590 and 619/617 in order to amplify
(Gibco BRL). After 48 hr the transfected HeLa cells werethe regions V1/V2 and V3. The secondary reactions were
cocultured with two million PHA-stimulated peripheralcarried out using 10 mM concentrations of each dNTP
blood lymphocytes (PBL) for 24 hr. The PBLs were recov-with the addition of 1 mCi 35S-dATP (1000 Ci/mmol; Amer-
ered from the HeLa monolayer, washed, and cultured insham) per reaction. Amplification conditions were as
IL-2 containing RPMI medium for 21 days with the addi-above. An equal volume of a mixture containing 98%
tion of fresh uninfected PBLs after 7 and 14 days. Theformamide, 10 mM EDTA, 0.1% bromophenol blue, and
extracellular fluid was tested for the presence of soluble0.1% xylene cyanol was added to the labeled PCR prod-
p24 antigen as described previously (McKeating et al.,ucts and were analyzed using native PAGE as described
1993a). The transfected HeLa and HeLa–CD4 cells werepreviously. Following electrophoresis the gels were fixed
monitored for their production of soluble and intracellularin 10% acetic acid/methanol and dried at 807 under vac-
p24 antigen. Cells were fixed with methanol:acetone (1:1uum prior to autoradiography (Simmonds et al., 1990b;
ratio, stored at 0207) and incubated with mAbs specificBall et al., 1994).
for p24 (MRC ADP repository), and bound antibodies
were detected with a b-galactosidase-conjugated anti-Site-directed mutagenesis and cloning of V1V2
mouse-Ig and X-gal as described previously (Claphamencoding region into HXB2
et al., 1992). Cells expressing p24 antigen give rise to a
colored focus, and those viruses capable of inducingA SalI/BamHI fragment of HXB2.MCS (McKeating et
al., 1993a) was cloned into M13mp19 and the restriction cytopathic effects (CPE) in the HeLa–CD4 cells result in
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TABLE 2
Summary of Length, Charge, and the Predicted Number of Glycosylation Sites in the V1V2 Region
Note. Sequences highlighted are those that were used for the construction of chimeric viruses (Table 3).
* Length in amino acids.
multinucleated foci which can be quantified. Both extra- HXB2.V1V2 chimeric plasmid template, using the condi-
tions described above (but with only 10 cycles of amplifi-cellular virus and infected PBLs were tested for their
cation). The PCR product was gel purified and 100 ngability to initiate infection with a panel of T-cell lines,
annealed to 25 ng of the vector pCDNA3.tpa, which incor-including MT2 , SupT1, and 8166 cells. T-cell lines were
porated complementary uracilated sequences, in themonitored for signs of cytopathic effect and p24 antigen
presence of 0.25 U of uracil deglycosylase (Gibco BRL,production.
Paisley, Scotland). The annealed vector was transformed
into competent TG2 cells as above. Colonies wereConstruction and expression of HXB2.V1V2 chimeric
screened for the presence of insert and plasmid DNAgp120 proteins
prepared as above. Two plasmids for each chimera were
The gp120 open reading frame was amplified using transfected, using Lipofectamine (Gibco BRL), into
primers 4142 and 4141, uracilated derivatives of the prim- VTF7.3-infected 293 cells. Cell supernatants were col-
lected after 72 hr, clarified by centrifugation at 1500 g,ers 626L and E524 described above, with 10 ng of
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FIG. 1. Analysis of length polymorphism in the V1V2 and V3 regions of gp120. The size(s) of the radiolabeled PCR products amplified from the
V1V2 and V3 regions of gp120 was measured by acrylamide gel electrophoresis. Sequential samples from each patient (P1–6) were analyzed in
adjacent lanes according to the order shown in Table 1. Markers of known molecular weight (HXB2) are also shown. A sequencing track was also
included to accurately determine the PCR product sizes (not shown). The size(s) of the V1V2 products ranged from 305 to 386 nucleotides and V3
from 366 to 378 nucleotides.
and assayed for gp120 levels in a quantitative gp120 contrast the V3 product was monotypic in length in each
sample. In three of the six patients, changes were seencapture ELISA (Moore et al., 1990).
Saturating concentrations (500 ng/ml) of soluble gp120 in V1V2 length during the course of the study. For exam-
ple, in patient 1, the V1V2 length pattern changed be-were tested for their ability to bind sCD4–Ig (10 mg/
ml) (Genentech, San Francisco, CA) and the mAbs 35/ tween the first and second time points sampled (38 days);
however, this new pattern then persisted over the re-25 (recognizing a V1V2V3 independent nonlinear gp120
epitope), 41.1 (specific for a nonlinear epitope within the mainder of the study period (470 days). Similarly, in pa-
tient 2 a stable pattern was observed from 397 to 645V3 region) (McKeating et al., 1992), 38/66c, 38/62c, 11/
68b, 55/39, and 55/27 (specific for a series of distinct days; however, at the next sampling point (706 days) a
markedly different pattern was seen. These data lead usnonlinear epitopes within the V2 region) (Shotton et al.,
1995). Bound ligands were visualized with either anti- to conclude that the stable pattern observed in patient 4
(203 days) does not constitute an aberrant finding. Thehuman Ig HRP or anti-rat Ig HRP (SeraLabs, Crawley,
UK), respectively. Results were expressed as a ratio of V1V2 PCR products were cloned into the pGEM-T vector
and the lengths of the resulting clones measured, suchthe optical density of the chimeric protein to HXB2 wild-
type protein and are termed the relative binding index. that the largest was named ‘‘A,’’ and inserts of decreasing
size labeled ‘‘B,’’ ‘‘C,’’ etc. (Table 2). The majority of lengths
RESULTS present in the bulk PCR mixture was cloned in all cases.
Amplification, cloning, and sequencing of the V1V2 Three clones of each length were sequenced, and pep-
region from proviral DNA tide translations shown in Fig. 2.
All of the length differences observed within a sampleThe proviral copy number present in the PBMC DNA
were attributable to changes in the V1 region, with thesamples was determined by limit dilution PCR and was
exception of sample 2 from patient 2, where a singleshown to be in excess of 100 copies of the gp120 coding
V2 amino acid deletion was observed (P2T7.C) (Fig. 2).region per 105 cell equivalents (data not shown). Nested
Differences in the length of the V1 region of up to 17amplifications of the V1V2 and V3 regions were per-
amino acids (aa) were found within a single sampleformed from a primary reaction derived from an initial
(P3T1) (Table 2); moreover, between all samples thetemplate concentration of at least 50 copies. In order to
length varied from 28 to 49 aa. In contrast the length ofvisualize small differences in size between PCR products
the V2 region was conserved, five of the six patients35S-dATP was included in the reaction mixture and sam-
studied having V2 sequences of 40 aa, whereas that ofples were analyzed on a 6% acrylamide gel. Multiple
the sixth was 46 aa. The V1 sequences have a highlengths of the V1V2 amplified product were observed,
ranging in size from 305 to 386 base pairs (Fig. 1). In frequency of the amino acids asparagine (N), serine (S),
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FIG. 2. Sequence alignment of the V1V2 region. Sequence alignments were generated using the program Clustal V. Three clones (1–3) were
sequenced for each of the different V1V2 lengths, labeled A–E, where A is the longest of the sequences from a sample. Two samples (shown in
Table 1) were sequenced from each of the six patients studied. The first cysteine of V1 (LNCTN) is defined as the first residue of V1; similarly, the
fist cysteine of V2 (NCSF) is defined as its first residue.
and threonine (T) resulting in the frequent occurrence stitutions was relatively conservative. However, we noted
that three samples from two patients (P1T1, P2T1, andof N–X–S/T triplets (where X denotes any amino acid)
encoding potential glycosylation sites in agreement with T7) had additional cysteine residues in the V1 region
(Fig. 2). In the case of P1T1 an additional cysteine wasthe observations reported by Bosch and colleagues
(1994). The number of predicted glycosylation sites within found in 3 of 15 clones, whereas 18 of 21 clones from
patient 2 contained two extra cysteines. It is possibleV1 varied from two to eight across the data set with
differences within a single sample of up to four sites that these residues could be involved in additional or
aberrant disulfide bridges. The cysteine residues of the(P3T1) (Table 2, Fig. 2). In contrast the majority of V2
sequences coded for either one or two predicted glyco- V1 region are predicted to form a disulfide bridge (Leo-
nard et al., 1990). The residues adjacent to the c-terminalsylation sites, the exception being the larger V2 region
of patient 3, which contained four predicted sites (Table cysteine of this bridge are reported as being well con-
served (Myers et al., 1993), with a published consensus2, Fig. 2).
Within the V1V2 region the pattern of amino acid sub- of GEIKNCSF; however, in two of the six patients studied
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FIG. 3. Consensus V2 sequence and predicted secondary structure. (A) A consensus, derived from a total of 93 sequences (Fig. 2), was calculated
by VESPA (Korber and Myers, 1992). The frequency at each position of each residue found is shown as a subscript to the single-letter amino acid
code (34). (B) Secondary structure prediction for the V2 region from the consensus sequence (Garnier et al., 1978), showing residues involved in
predicted a-helix (H) and b-pleated sheet (E) motifs.
we found this sequence to be absent. In patient 6, the tively (Table 1). However, the mean pairwise distances
between sequences within the same samples rangedcorresponding motif was EENTCSF, whereas in patient
2 no consensus was found. The heterogeneity observed from 0.08 to 5.4%. Given this high level of intrasample
variation we are unable to demonstrate any relationshipin the V1 region, with respect to both length and se-
quence, makes it difficult to infer a consensus for this between percentage divergence and sampling interval.
Since V2 conformation is affected by changes in V1data set, and in contrast the V2 region can be aligned
to give a consensus (Fig. 3). Ten of the residues in the (McKeating et al., 1993a), and both V1 and V2 form a
disulfide bridged double loop structure (Leonard et al.,V2 region were found to be completely invariant, includ-
ing the terminal cysteines, and a further 19 residues were 1990), we were interested to see if there was any evi-
dence of genetic linkage between the two variable re-conserved in greater than 75% of the clones obtained
(Fig. 3). Secondary structure prediction for the consensus gions (Simmonds et al., 1990b). We reanalyzed the data
as two subsets (V1 and V2) and compared the results forV2 sequence suggests the presence of both a-helix and
b-pleated sheet motifs (Fig. 3) (Garnier et al., 1978). each region alone with the complete data set (programs
SEQBOOT, NEIGHBOR, and CONSENSE). When the
agreement between V1 and V2 subsets was tested, theAnalysis of V1V2 sequences and measurement of
branches which defined the groupings for patients 1, 3,their phylogenetic relationships
and 5 were shown to be consistent irrespective of the
The relationships between the sequences obtained region used. However, when the V2 region alone was
were assessed by neighbor-joining, distance matrix, and considered, some sequences from patient 6 were found
maximum likelihood analyses. Both nucleic acid se- to be indistinguishable from those found in patient 4.
quences and their protein translations were analyzed, Similarly, some V1 sequences from patient 2 were found
and congruent results were seen with both data sets. to be more related to those found in patient 4 than they
Maximum likelihood and bootstrap resampling analysis were to each other. These data suggest that the V1 and
of the data showed that sequences from a patient shared V2 regions are evolving independently of each other.
enough common properties to form monophyletic
groups, though it was possible in some cases to discrimi- Construction and characterization of HXB2 clones
nate completely between sequences obtained at differ- chimeric for the V1V2 region
ent times. This result confirms the independence of the
samples used in this study. Some internal branches, dis- Two unique restriction sites, HpaI and NgoMI, were
introduced into the viable molecular clone pHXB2.MCScriminating between the first and second samples from a
single patient, were longer than those observed between to enable the transfer of V1V2 regions from the pGEM-T
plasmids (Fig. 5). No differences were observed betweendifferent patients, suggesting that, in some cases, there
are more differences between the intrapatient se- the replication rate of viruses derived from either
pHXB2.HpaI/NgoMI or the parental clone in primaryquences than between independent samplings from the
study population (Fig. 4). The mean pairwise difference PBMC cultures and T-cell lines (data not shown). Several
V1V2 clones representing both frequent and relativelybetween the two time points sampled ranged from 0.23
(patient 6) to 6.4% (patient 5), and the interval between rare sequences present in the PBMC population were
chosen for transfer into this vector. These chimeric plas-samples in these patients was 711 and 98 days, respec-
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FIG. 4. Phylogenetic relationships between the V1V2 sequences. Sequence relationships were inferred from the data in Fig. 2 using the neighbor-
joining algorithm (NEIGHBOR) (11). Although shown as a dendogram for clarity, no inference of ancestry is implied. The locations of the sequences
for each patient are shown.
mids were transfected into HeLa–CD4 cells and gen(s) give rise to colored foci, enabling us to assess
both transfection efficiency and cytopathicity (Table 3).screened for viral replication by measuring both p24 and
gp120 antigen production. Cells expressing viral anti- Transfection of all plasmids gave rise both to soluble
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FIG. 5. Location of restriction sites for construction of V1V2 chimeras. The position and sequence of primers 589 and 590, used to generate the
V1V2 sequence insert, are shown. The site-directed changes introducing the restriction sites HpaI and NgoMI are shown in lower case. The C2
region indicated was conserved in all patients with the exception of patient 2 (P2) where the single amino acid change S/T was found.
(3.0–20.0 ng/ml) and intracellular p24 antigen, and some
constructs gave rise to multinucleated foci, whereas oth-TABLE 3
ers, cloned from the same patient, resulted in single cellsTransfection of HXB2.V1V2 Chimeric Plasmids and Their
staining positive (Table 3). We tested the ability of theReplication in T-Cell Lines
extracellular supernatant to establish infection in a num-
Patient, Transfection in Hela– ber of different T-cell lines (SupT1, MT2, and 8166). All
time, CD4a Replicationb in of the viruses capable of inducing CPE in the transfected
and
HeLa–CD4 cells were also capable of infecting the T-label No. foci Cytopathicity MT-2 SupT1 8166
cell lines tested, giving rise to both CPE and soluble
p24 antigen (Table 3). In order to assess whether thoseHXB2 112 /// // /// ///
viruses which failed to establish infections in T-cell linesP1 T1.B1 105 // / // //
were viable we tested their ability to replicate in primaryP1 T1.C3 101 / / / /
PBMC cultures. HeLa cells were transfected with the
P2 T1.A1 110 0 0 0 0
constructs and, after 48 hr, cocultured with PHA blastsP2 T1.B1 98 0 0 0 0
for 24 hr. These primary cultures were maintained for 21P2 T1.C1 97 0 0 0 0
days and monitored for viral replication (Table 4). OnceP2 T1.D1 101 /// / // ///
P2 T7.A1 121 // / // /// cultures were shown to be positive for soluble p24 anti-
P2 T7.B1 94 0 0 0 0 gen, PBMC-MT2 cocultivations were performed and
P2 T7.C1 111 // / // //
monitored for CPE (Table 4). In summary, four constructs
P3 T1.A1 92 0 0 0 0 yielded nonviable virus, five constructs resulted in virus
P3 T1.C1 106 0 0 0 0 only capable of replication in PBMC cultures, and the
P3 T1.D1 94 0 0 0 0
remaining seven constructs generated virus capable ofP3 T5.A1 90 0 0 0 0
replicating in all cell types tested (Tables 3 and 4).
P5 T2.A1 116 // // // //
P5 T2.A2 107 // // // //
Expression and characterization of HXB2.V1V2P5 T2.B1 87 0 0 0 0
chimeric gp120 envelope glycoproteins
a 5 mg of plasmid was transfected in triplicate and the mean number
of infected foci counted per well. The results are representative of a The V2 region has been reported to interact with both
single experiment. The experiment was repeated four times. the V3 (Koito et al., 1994, 1995) and the C4 regions ofb Extracellular supernatant from the transfected HeLa–CD4 cell was
gp120 (Andeweg et al., 1993; Freed and Martin, 1994;measured for soluble p24 antigen content and equivalent amounts of
Gram et al., 1994). It is therefore possible that replace-p24 containing virus were used to infect MT-2, SupT1, and 8166 cells.
Cells were monitored for both cytopathicity and p24 antigen production. ment of the V1V2 region of HXB2 with an alternative
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TABLE 4
Replication of HXB2.V1V2 Chimeric Viruses in PBMC Cultures and T-Cell Lines
CPE in CPE in
Patient Replication in PBMC p24 ng/ml (days p.i.)a MT2– SupT1–
time and Syncytia in PBMC PBMC
label 3 5 10 PBL culture cocultivation cocultivation
HXB2 5.0 10.0 10.0 / /// ///
P1 T1.B1 2.5 10.0 10.0 / // //
P1 T1.C3 1.8 10.0 10.0 // // //
P2 T1.A1 0.3 0.6 2.3 0 0 0
P2 T1.B1 0.4 0.8 1.6 0 0 0
P2 T1.C1 0.2 0.9 1.3 0 0 0
P2 T1.D1 2.6 8.5 10.0 / / /
P2 T7.A1 0.2 1.7 10.0 / / /
P2 T7.B1 ud ud ud 0 0 0
P2 T7.C1 2.3 10.0 10.0 / / /
P3 T1.A1 0.3 0.5 0.7 0 0 0
P3 T1.C1 0.2 0.4 0.6 0 0 0
P3 T1.D1 ud ud ud 0 0 0
P3 T5.A1 ud ud ud 0 0 0
P5 T2.A1 2.5 10.0 10.0 / / /
P5 T2.A2 3.5 10.0 10.0 / / /
P5 T2.B1 ud ud ud 0 0 0
a ud, undetectable p24 antigen.
divergent sequence may lead to a misfolded molecule, typic changes affecting both cytopathicity and cell tro-
pism. It is of interest to note that a number of chimericresulting in a nonviable virus. In order to test this hypoth-
esis we cloned and expressed the gp120 proteins from viruses were noncytopathic and unable to replicate in T-
cell lines despite having a positively charged ‘‘SI’’ V3 loop.a number of viable and nonviable chimeric constructs.
Transfection of all pCDNA.3 expression constructs re- These data demonstrate that the V1V2 region, indepen-
dent of V3 sequence, affects cytopathicity of the envelopesulted in equivalent levels of extracellular soluble gp120
(1–2.4 mg/ml). The soluble gp120 proteins were tested glycoprotein, suggesting that care should be taken in
predicting SI or NSI phenotypes based on V3 sequencesfor their ability to bind sCD4–Ig; mAb 35/25 specific for
a discontinuous epitope independent of the CD4 binding alone.
Sequencing of the clones localized the intrasamplesite; mAb 41.1 specific for a discontinuous V3 epitope;
and mAbs 38/66c, 38/62c, 11/68b, 55/39, and 55/27 spe- length polymorphism to the V1 region, with the exception
of a single amino acid V2 deletion in a minority of clonescific for a number of discontinuous epitopes within V2
(Table 5). All of the chimeric proteins bound sCD4–Ig from patient 2 (P2T7.C). The extreme N-terminal eight
amino acids of V1 were conserved in all clones, sug-and mAbs 35/25 and 41.1 equivalently. All of the V2 mAbs
were raised against a recombinant LAI (clone BH10) gesting that the residues adjacent to the two cysteines
are invariant. In contrast, the carboxyl-terminus of V1gp120 and hence show preferential reactivity toward the
HXB2 protein, with the exception of mAbs 55/39 and 55/ (Myers et al., 1993), for which the published consensus
sequence is GEIKNCSF, varied in samples from two of27 which recognize the majority of the chimeric proteins
tested (Table 5). These data suggest that the chimeric the six individuals, suggesting that this region may be
gp120 proteins were correctly processed and demon- more plastic than previously thought. The positions of
strated ‘‘correct’’ conformation as assessed by their abil- predicted N-linked glycosylation sites were not con-
ity to bind ligands specific for discontinuous epitopes. served (Fig. 2 and Table 2) in contrast to the report of
Wang and colleagues (1995), who obtained consensus
V1 sequences from direct sequencing of PCR products.DISCUSSION
We found different V1 lengths at comparable frequencies
in the original PBMC samples, suggesting that directFunctional analysis of naturally occurring V1V2 variant
sequencing of PCR products would underestimate thesequences demonstrates that both substitutional and
length changes found in this region may result in pheno- level of variation present. We (Shotton et al., 1995) and
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TABLE 5
Expression and Characterization of HXB2.V1V2 Chimeric Soluble gp120 Proteins
pCDNA.3 Replication in Relative ability a of soluble gp120 proteins to bind to conformation-dependent ligands
clone
label PBMC T-cells CD4–Ig 35/25 41.1 38/66c 38/62c 11/68b 55/39 55/27
HXB2 / / 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
P1T1.C3 / / 1.18 0.96 1.03 0.01 0.44 0.42 0.01 0.01
P2T1.D1 / / 1.02 1.00 0.96 0.01 0.30 0.35 1.30 1.45
P2T7.A1 / / 1.13 1.02 0.97 0.01 0.21 0.34 0.02 0.02
P2T7.B1 0 0 1.04 0.88 0.98 0.01 0.31 0.24 1.23 1.63
P2T7.C1 / / 1.03 0.92 1.04 0.05 0.28 0.26 1.45 1.57
P3T1.A1 / 0 1.25 0.91 1.02 0.01 0.01 0.42 0.18 0.19
P3T1.C1 / 0 1.19 0.87 1.00 0.01 0.02 0.40 1.33 1.45
P3T1.D1 0 0 0.94 0.95 0.79 0.01 0.01 0.33 0.51 0.53
P5T2.A1 / / 1.18 0.90 0.97 0.01 0.03 0.47 0.90 0.91
a Chimeric V1V2.HXB2 proteins were compared with a reference gp120 (LAI clone HXB2) for their ability to bind CD4–Ig or mAbs, 35/25, 41.1,
38/66c, 38/62c, 11/68b, 55/39, and 55/27 recognizing conformation-dependent epitopes within gp120.
others (Back et al., 1994) have reported that addition or the context of a constant genetic background. Two pairs
of chimeric constructs differed from one another only inremoval of glycans affects the ability of mAbs to bind
and neutralize HIV. There is little evidence to support the the V1 region (P2T1 clones B1 and C1; P5T2 clones A1
and A2); however, each of the pairs exhibited the sameantigenicity of the V1 region; however, additional glyco-
sylation sites and increasing V1 length may have an ef- pattern of cell tropism (Table 4). These data suggest
that differences in V1 within these clones had no majorfect on envelope conformation. In support of such a hy-
pothesis, Gram and colleagues (1994) reported that the influence on the pattern of tropism (Table 2). Sequences
from two individuals containing one or more additionalloss of a single glycosylation site within V1 affected the
ability of V3 specific antibodies to neutralize the variant cysteines within the V1 region, when cloned into HXB2,
resulted in viable viruses (Fig. 2 and Table 4). It is inter-virus.
The V2 region was less variable than V1, with respect esting to note that Gao and colleagues (1996) also re-
ported polymorphism in both the number and the locationto both length and substitutional changes, allowing us
to align a consensus sequence (Fig. 3). It is interesting of cysteine residues within a panel of divergent env
genes; however, these authors did not assess whetherto note that our V2 consensus agreed with that reported
by Wang and colleagues (1995) at 31/33 residues if the such sequences were able to encode correctly folded
glycoproteins.variable locus between residues 185 and 191 was ig-
nored. The majority of changes was conservative; for Chimeras expressing closely related V1V2 sequences
cloned from the same sample displayed different biologi-example, the 13 hydrophobic amino acids were con-
served in 82–100% of sequences present in both studies. cal phenotypes, with respect to both cytopathicity and
the ability to replicate in T-cell lines (Tables 3 and 4). ForGiven the relatively conserved nature of the V2 region it
is unsurprising that samples from independently infected example, viruses A1, B1, and C1 expressing V1V2 regions
from patient 2 (P2T1) were able to replicate only in PBMCindividuals should show identical V2 sequences (patients
4 and 6), and such clear evidence of convergence also cultures and failed to induce CPE, whereas virus ex-
pressing the D1 sequence from the same sample wasimplies a selective constraint on this region. In
agreement with these observations, the average dn/ds cytopathic and capable of replicating in both T-cell lines
and PBMC cultures (Tables 3 and 4). There are only fourratio for the V1V2 region was found to be greater than
one, implying that this region is under positive selection, substitutions (V1 position 31 E/K and in V2 positions 6
T/A, 11 K/N, and 31 D/N, respectively) and a two aasimilar to that reported for V3 (Holmes et al., 1992, 1993).
This restricted sequence variability is reflected in the deletion in the V1 region between clones B1 and D1,
such that mutagenesis of these clones would allow theconservation of neutralization epitopes (Table 5) (Kayman
et al., 1994; manuscript in preparation). fine mapping of the residue(s) responsible for the differ-
ences in their cell tropism. Overall, these data suggestThe majority of chimeric viruses replicated, demon-
strating that the V1V2 sequences, though genetically dis- that length polymorphism within V1 can be accommo-
dated without obvious biological differences. In sum-tinct, were capable of conferring a viable phenotype in
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mary, we have observed different patterns of viral pheno- ence of signature patterns (VESPA) (Korber and Myers,
1992) and found no association between amino acid mo-type in that chimeras expressing sequences from P1
were all MT2 cell tropic, P5 were either nonviable or MT2 tifs and viability or cytopathicity. Furthermore, no associa-
tion was found between length of either V1 or V2, pres-cell tropic, P3 were either nonviable or PBMC restricted,
and finally clones from P2 demonstrated all three pheno- ence of charged residues, predicted glycosylation pat-
terns, measurements of hydrophobicity/hydrophilicity,types (Table 4). It is probable that a less polymorphic
sample set, such as that derived from a viral isolate, and viability of chimeric viruses. We therefore conclude
that the analytical methods currently available are inade-would not show this spectrum of phenotypes.
We, and others, have suggested possible interaction(s) quate for the prediction of viral phenotype from primary
sequence data. However, the observation that transferbetween V2 and both the V3 and CD4 b.s. regions (Fou-
chier et al., 1992; Shioda et al., 1992; McKeating et al., of the V1V2 region into the HXB2 molecular clone can
modulate the ability of a virus to replicate in T-cell lines1993b; Sullivan et al., 1993; Freed and Martin, 1994). We
found that chimeric viruses with distinct V2 sequences cells clearly shows this region of the envelope glycopro-
tein to be an important determinant of viral tropism.(P1T1.C3, P2T1.D1, P2T7.A1, and P5T2.A1, differing from
one another by an average of 3.2%) all replicated in T-
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